Kitzmiller JL. Macrosomia in infants of diabetic mothers: characteristics, causes, prevention. In: Jovanoic L, Peterson CM, Fuhrmann K eds. Diabetes and pregnancy: teratology, toxicology and treatment. New York: Praeger. 1986, 85–120.
Google Scholar
Fowden AL. The role of insulin in fetal growth. In: Sakamoto S, Takeda Y eds. Advances in perinatal medicine. Amsterdam: Elsevier. 1992, 177–81.
Google Scholar
Wang HS, Lim J, English J, Irvine L, Chard T. The concentration of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in human umbilical cord serum and delivery: relation to fetal weight. J Endocrinol 1991, 129: 459–64.
PubMed
Article
CAS
Google Scholar
Shaarawy M, el-Mallah SY. Leptin and gestational weight gain: Relation of maternal and cord blood leptin to birth weight. J Soc Gynecol Investig 1999, 6: 70–3.
PubMed
Article
CAS
Google Scholar
Wiznitzer A, Reece EA, Homko C, Furman B, Mazor M, Levy J. Insulin-like growth factors, their binding proteins and fetal macrosomia in offspring of nondiabetic pregnant women. Am J Perinatol 1998, 15: 23–8.
PubMed
Article
CAS
Google Scholar
Reece EA, Wiznitzer A, Le E, Homko CJ, Behrman H, Spencer EM. The relation between human fetal growth and fetal blood levels of insulin-like growth factors I and II, their binding proteins, and receptors. Obstet Gynecol 194, 84: 88–95.
Collett-Solberg PF, Cohen P. The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action. Endocrinol Metab Clin North Am 1996, 25: 591–614.
PubMed
Article
CAS
Google Scholar
Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005, 115: 290–6.
Article
Google Scholar
Langer O. Fetal macrosomia: etiologic factors. Clin Obstet Gynecol 2000, 43: 283–97.
PubMed
Article
CAS
Google Scholar
Breschi MC, Seghieri G, Bartolomei G, Gironi A, Baldi S, Ferrannini E. Relation of birth weight to maternal plasma glucose and insulin concentrations during normal pregnancy. Diabetologia 1993, 36: 1315–21.
PubMed
Article
CAS
Google Scholar
Holt RI. Fetal programming of the growth hormone-insulin-like growth factor axis. Trends Endocrinol Metab 2002, 13: 392–7.
PubMed
Article
CAS
Google Scholar
Mazaki-Tovi S, Kanety H, Pariente C, Hemi R, Schiff E, Sivan E. Cord blood adiponectin in large-for-gestational age newborns. Am J Obstet Gynecol 2005, 193: 1238–42.
PubMed
Article
CAS
Google Scholar
Altman D. Sample size. In: Practical statistics for medical research. London: Chapman & Hall 1994, 456–60.
Google Scholar
Skjaerbaek C, Vahl N, Frystyk J, et al. Serum free insulin-like growth factor-I in growth hormone-deficient adults before and after growth hormone replacement. Eur J Endocrinol 1997, 137: 132–7.
PubMed
Article
CAS
Google Scholar
Sun M, Schutz Y, Grezzani A, Clementi M, Gaudino R, Maffeis C. Body size and early growth in appropriate- and large-for-gestational-age infants. Acta Paediatr 2003, 92: 1127–32.
PubMed
Article
CAS
Google Scholar
Hediger ML, Overpeck MD, Maurer KR, Kuczmarski RJ, McGlynn A, Davis WW. Growth of infants and young children born small or large for gestational age: findings from the Third National Health and Nutrition Examination Survey. Arch Pediatr Adolesc Med 1998, 152: 1225–31.
PubMed
Article
CAS
Google Scholar
Binkin NJ, Yip R, Fleshood L, Trowbridge FL. Birth weight and childhood growth. Pediatrics 1988, 82: 828–34.
PubMed
CAS
Google Scholar
Juul A, Main K, Blum WF, Lindholm J, Ranke MB, Skakkebaek NE. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clin Endocrinol (Oxf) 1994, 41: 85–93.
Article
CAS
Google Scholar
Gelander L, Blum WF, Larsson L, Rosberg S, Albertsson-Wikland K. Monthly measurements of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in healthy prepubertal children: characterization and relationship with growth: the 1-year growth study. Pediatr Res 1999, 45: 377–83.
PubMed
Article
CAS
Google Scholar
Löfqvist C, Anderson E, Delander L, et al. Reference values for insulin-like growth factor-binding protein-3 (IGFBP-3) and the ratio of Insulin-like growth factor-I to IGFBP-3 throughout childhood and adolescence. J Clin Endocrinol Metab 2005, 90: 1420–7.
PubMed
Article
CAS
Google Scholar
Patel L, Cavazzoni E, Whatmore AJ, et al. The contributions of plasma IGF-I, IGFBP-3 and leptin to growth in extremely premature infants during the first two years. Pediatr Res 2007, 61: 99–104.
PubMed
Article
CAS
Google Scholar
Buckway CK, Selva KA, Pratt KL, Tjoeng E, Guevara-Aguirre J, Rosenfeld RG. Insulin-like growth factor binding protein-3 generation as a measure of GH sensitivity. J Clin Endocrinol Metab 2002, 87: 4754–65.
PubMed
Article
CAS
Google Scholar
Brismar K, Fernqvist-Forbes E, Wahren J, Hall K. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin dependent diabetes. J Clin Endocrinol Metab 1994, 79: 872–8.
PubMed
CAS
Google Scholar
Saitoh H, Kamoda T, Nakahara S, Hirano T, Matsui A. Insulin-like growth factor binding protein-1 as a predictor of glucose-stimulated hypeinsulinemia in prepubertal obese children. Eur J Endocrinol 1999, 140: 231–4.
PubMed
Article
CAS
Google Scholar
Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB, Wareham NJ. Circulating concentrations of Insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 2002, 359: 1740–5.
PubMed
Article
CAS
Google Scholar
Yang WS, Lee WJ, Funahashi T, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001, 86: 3815–9.
PubMed
Article
CAS
Google Scholar
Sadick MD. Kinase Receptor Activation (KIRA): a rapid and accurate alternative to endpoint bioassays. Dev Biol Stand 1999, 97: 121–33.
PubMed
CAS
Google Scholar
Chen JW, Ledet T, Orskov H, et al. A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum. Am J Physiol Endocrinol Metab 2003, 284: E1149–55.
PubMed
CAS
Google Scholar